The Effects of Bindarit in Preventing Stent Restenosis
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The main study objective is to assess the efficacy and safety of different bindarit dosages
compared to placebo in preventing restenosis, in patients submitted to coronary stenting and
using a bare metal stent (Vision BMS, by Abbott).